ScreenerHero
HCAHCA Healthcare, Inc.
NYSE · US · Healthcare · Medical Care Facilities · hcahealthcare.com
429.91USD+5.62%Mkt Cap: 90.30B $P/E: 13.65

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities,…

Industry Peers

Medical Care Facilities
Screen all
FRE
Fresenius SE & Co. KGaA Inhaber-Aktien o.N.
$28.29BUSDP/E 16.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG & Co. KGaA
$11.94BUSDP/E 12.3
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
Emeis SA
$2.46BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5
ADUS
Addus HomeCare Corporation
$2.24BUSDP/E 21.0

Key Statistics

Company
Market Cap90.30B $
Enterprise Value141.81B $
Revenue (TTM)78.01B $
Gross Profit31.37B $
Net Income (TTM)6.78B $
Revenue/Share345.31 USD
Last Price429.91 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees230.0K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISINUS40412C1018
Valuation
P/E (Trailing)13.65
P/E (Forward)12.65
PEG1.32
EV/EBITDA9.01
EV/Revenue1.82
P/S1.13
P/B-13.33
EPS (TTM)29.78
EPS (Forward)32.11
52W Range
354.0037% of range556.52
52W High556.52 USD
52W Low354.00 USD
Profitability
Gross Margin41.50%
Oper. Margin15.16%
EBITDA Margin20.18%
Profit Margin8.97%
ROE-112.56%
ROA11.17%
Growth
Revenue Growth8.70%
Earnings Growth11.60%
Cash Flow & Leverage
Operating CF12.64B $
CapEx (TTM)4.94B $
FCF Margin4.79%
FCF Yield4.14%
Net Debt50.42B $
Net Debt/EBITDA3.20
Balance Sheet
Debt/Equity-8.08
Current Ratio0.99
Quick Ratio0.78
Book Value/Sh-30.4730 USD
Cash/Share5.219 USD
Dividends
Fwd Div Rate3.120 USD
Trail. Div Rate3.000 USD
Div. Yield0.77%
5Y Avg Yield0.78%
Payout Ratio10.06%
Ex-Div DateSep 16, 2026
Pay DateSep 30, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)451.48 USD
Upside (mean)+5.0%
Target Range380.00 USD – 579.00 USD
$380.00+5.0% to mean$579.00
# Analysts21
Ownership
Shares Out.221.84M
Float144.32M
Insiders16.61%
Institutions78.96%
Short Interest
Short Ratio3.4d
Short % Float4.30%
Short % Out.2.80%
Shares Short6.06M
Short (prev mo.)5.35M
Technical
SMA 50395.52 (+8.7%)
SMA 200454.88 (-5.5%)
Beta1.11
S&P 52W Chg18.16%
Avg Vol (30d)1.31M
Avg Vol (10d)1.14M
Technical Indicators
RSI (14)53.5
MACD4.5005
MACD Signal4.6025
MACD Hist.-0.1021
BB Upper428.68 USD
BB Middle402.63 USD
BB Lower376.59 USD
BB Width12.94%
ATR (14)12.23 USD
Vol Ratio (20d)1.03x